Edition:
United States

Innophos Holdings Inc (IPHS.OQ)

IPHS.OQ on NASDAQ Stock Exchange Global Select Market

47.55USD
3:45pm EDT
Change (% chg)

$0.30 (+0.63%)
Prev Close
$47.25
Open
$47.05
Day's High
$47.87
Day's Low
$47.05
Volume
18,497
Avg. Vol
42,677
52-wk High
$58.21
52-wk Low
$37.26

Latest Key Developments (Source: Significant Developments)

GenNX360 Capital Partners enters agreement to sell Novel Ingredients to Innophos Holdings Inc
Tuesday, 1 Aug 2017 08:30am EDT 

Aug 1 (Reuters) - Innophos Holdings Inc :GenNX360 capital partners enters agreement to sell Novel Ingredients to Innophos Holdings Inc.  Full Article

Innophos Holdings says on July 28, unit entered agreement, plan of merger
Tuesday, 1 Aug 2017 08:16am EDT 

Aug 1 (Reuters) - Innophos Holdings Inc ::Innophos holdings - ‍on July 28, co, unit of co, Gennx Novel Holding, Gennx Novel representative​ entered into agreement, plan of merger - SEC filing.Innophos holdings inc - ‍company will pay holders of Novel's common stock and options aggregate consideration of $125 million in cash​.Innophos holdings inc - expects to finance merger with cash on hand and borrowings under company's credit facility.Innophos holdings inc - merger agreement may be terminated by either party if merger has not been consummated by September 26, 2017.  Full Article

Innophos to acquire Novel Ingredients to create a nearly $0.5 bln food, health and nutrition platform
Tuesday, 1 Aug 2017 07:01am EDT 

Aug 1 (Reuters) - Innophos Holdings Inc :Innophos to acquire novel ingredients to create a nearly $0.5 billion food, health and nutrition platform.Says ‍total purchase price of $125 million (enterprise value), payable in cash​.Innophos Holdings Inc - ‍acquisition is expected to be accretive to Innophos' earnings per share in first year following close of transaction​.Says ‍will fund acquisition with borrowings under its existing credit facility​.Innophos Holdings Inc says company anticipates cost and tax synergies of approximately $15 million from deal.  Full Article

Innophos Holdings Inc Q2 earnings per participating share $0.57
Tuesday, 1 Aug 2017 07:00am EDT 

Aug 1 (Reuters) - Innophos Holdings Inc :Innophos Holdings, Inc. Reports second-quarter 2017 results.Sees fy 2017 revenue down about 4 percent.Innophos Holdings Inc - reiterates full year 2017 revenue and earnings guidance, excluding impact of novel ingredients acquisition.Innophos Holdings Inc - sales in Q3 are expected to be similar to Q2 2017, down approximately 4% year over year.Innophos holdings inc qtrly net sales $179.1 million versus $181.9 million.Innophos Holdings Inc qtrly diluted earnings per participating share $0.57.Innophos Holdings Inc - earnings in Q3 are forecast to be positively affected sequentially by reduced implementation fees, among others.Innophos Holdings Inc - anticipates phase 2 operational excellence fees incurred in first half of year "will be more than offset" by phase 2 savings.  Full Article

Innophos Holdings Q1 adjusted earnings per share $0.59
Monday, 1 May 2017 04:05pm EDT 

May 1 (Reuters) - Innophos Holdings Inc ::Innophos Holdings Inc - sales comparables in q2 are expected to improve sequentially, but still be down approximately 5% year-over-year.Innophos Holdings, Inc. Reports first quarter 2017 results.Q1 adjusted earnings per share $0.59.Q1 earnings per share $0.55.Q1 sales $166 million versus I/B/E/S view $167.5 million.Q1 earnings per share view $0.52 -- Thomson Reuters I/B/E/S.Innophos holdings inc - anticipates that tax rate will return to more normalized level of approximately 33% beginning in Q2.Innophos holdings inc - on a full year basis, overall market conditions and competitive landscape for 2017 are expected to be similar to 2016.Innophos holdings inc sees volume headwinds are expected to remain through balance of year, pruning effects are expected to improve in second half of year.Innophos holdings inc - continues to expect full year revenues to be down by 4% compared with 2016.Innophos holdings inc - full year earnings are expected to be broadly in line with 2016.Innophos holdings sees earnings in q2 impacted by remainder of consulting fees for implementation of phase 2 of "operational excellence initiatives".Innophos holdings sees phase 2 operational excellence fees incurred in first half of year offset by phase 2 savings;$5 million to take effect in second half of 2017.  Full Article

Innophos Holdings reiterates Q1 2017 expectations and 2017 guidance
Wednesday, 5 Apr 2017 08:15am EDT 

Innophos Holdings Inc : Innophos holdings inc - targeting $1.25 billion revenue and 20% adjusted ebitda by 2022 . Innophos holdings inc - reiterates q1 2017 expectations and 2017 guidance . Innophos holdings inc - sees q1 net income expected to be in range of $10 million to $11 million . Innophos holdings inc - sees q1 sales for quarter expected to be similar to q4 2016 . Q1 earnings per share view $0.65, revenue view $181.7 million -- Thomson Reuters I/B/E/S .Fy2017 earnings per share view $2.58, revenue view $704.1 million -- Thomson Reuters I/B/E/S.  Full Article

Innophos holdings Inc reports Q4 GAAP earnings per share $0.47
Tuesday, 21 Feb 2017 04:15pm EST 

Innophos Holdings Inc : Innophos holdings, inc. Reports fourth quarter and full year 2016 results . Q4 adjusted earnings per share $0.52 . Q4 GAAP earnings per share $0.47 . Q4 sales $168 million versus I/B/E/S view $153.4 million .Q4 earnings per share view $0.48 -- Thomson Reuters I/B/E/S.  Full Article

Innophos secures long-term viability of Geismar phosphoric acid facility
Thursday, 12 Jan 2017 04:05pm EST 

Innophos Holdings Inc : Innophos secures long-term viability of geismar phosphoric acid facility . Innophos holdings inc - innophos will pursue implementation of "deep well injection", a customary process approved by government parties . Says estimates that capital expenditure for deep well injection system will be $16 million . Innophos -settlement with epa and louisiana department of environmental quality to address concerns regarding a small number of manufacturing processes at ppa facility . Innophos holdings -majority of cost is expected to take effect in 2017,with about $2 million of preliminary engineering, equipment investments completed in 2016 . Innophos holdings-settlement confirms several voluntary improvements previously made to geismar facility to address environmental concerns . Innophos holdings inc says estimates that capital expenditure for deep well injection system will be $16 million .Innophos holdings inc - innophos has agreed to a penalty in amount of $1.4 million, which was previously fully accrued by company.  Full Article

Innophos enters into expanded $450 mln senior secured bank credit facility
Thursday, 22 Dec 2016 04:05pm EST 

Innophos Holdings Inc : Innophos enters into expanded $450 million senior secured bank credit facility . Innophos Holdings has entered into a new senior secured credit facility with group of bank lenders, increasing borrowing capacity by $125 million to $450 million . Innophos holdings says $450 million revolving credit line with a letter of credit subfacility of up to $20 million . Innophos holdings says credit facility effectively replaces senior credit facility entered into on December 21, 2012, as subsequently amended .Innophos enters into expanded $450 million senior secured bank credit facility.  Full Article

Innophos Holdings posts Q3 adj. earnings per share $0.75
Thursday, 27 Oct 2016 04:05pm EDT 

Innophos Holdings Inc : Innophos Holdings Inc reports third quarter 2016 results . Q3 adjusted earnings per share $0.75 . Q3 earnings per share $0.69 . Q3 sales fell 7 percent to $186 million . Q3 earnings per share view $0.65 -- Thomson Reuters I/B/E/S . Specialty phosphates volumes are expected to decline by 6-8 pct for full year 2016 compared with 2015 . Net income and adjusted EBITDA for Q4 are expected to be "somewhat softer" compared with first and Q2 2016 .2016 capital expenditures are expected to be in range of $34 million to $36 million.  Full Article

BRIEF-Innophos Holdings says on July 28, unit entered agreement, plan of merger

* Innophos holdings - ‍on July 28, co, unit of co, Gennx Novel Holding, Gennx Novel representative​ entered into agreement, plan of merger - SEC filing